About Juniper Biomedical
Juniper Biomedical is a Healthcare company based in Worcester (United States) founded in 2019 by Mario Romero Ortega and David N Constantine. It operates as an a neuromodulation platform is provided for pelvic health therapy. It operates in the Healthcare and Technology sectors. Juniper Biomedical has raised $2 million across 2 funding rounds from investors including NIH, Aatma Capital and Beacon Angels. Its chief executive is David N Constantine. Juniper Biomedical offers products and services including Neuromodulation Platform. Its focus areas include HealthTech, Disease Self Management, Genitourinary and Therapy. Its competitors include Minze Health, INNOVO, Jude, Starling Medical and inContAlert and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Juniper Biomedical was founded in 2019 in Worcester, United States, within the biomedical sector. A platform is operated to deliver therapy for pelvic health conditions through neuromodulation techniques. Normal neuromuscular function is restored in damaged pelvic floor tissue, while bladder activity is calmed. Treatment is focused on urinary incontinence, bowel incontinence, pelvic pain, sexual dysfunction, and related issues, with services accessible via the domain juniperbiomedical.com.
- Headquarters Worcester, United States
- Founders Mario Romero Ortega, David N Constantine
- SectorsHealthcareTechnology
- Email••••••••
- Website juniperbiomedical.com
- Social LinkedIn
- Total Equity Funding$2M (USD)
in 2 rounds
- Latest Funding Round$1M (USD), Grant
May 2024
- InvestorsNIH
& 4 more
Products & Services of Juniper Biomedical
Juniper Biomedical offers a comprehensive portfolio of products and services, including Neuromodulation Platform.
Implantable technology for treating pelvic health conditions.
Funding Insights of Juniper Biomedical
Juniper Biomedical has successfully raised a total of $2M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2M
- Total Rounds 2
- Last Round Grant — $1M
- First Round $2M
(Apr 2024)
- Investors Count 5
All 2 funding rounds of Juniper Biomedical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2024 | $1M | Grant | – | – | |
| Apr 2024 | $2M | Seed | – | Auroral Holdings |
5 investors in total: 5 institutional.
Investors in Juniper Biomedical
Juniper Biomedical has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Aatma Capital and Beacon Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage investments are made in fast-growing startups by Beacon Angels. | 2006 | beaconangels.com | Boston, United States | |
Angel Network for companies based in Boston | – | hubangels.com | Boston, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Provides direct and syndicated lending to MSMEs, building client relationships in finance. | 2018 | aatmacapital.com | Chennai, India | |
- | – | auroralholdings.tcc.mode | - |
Investor details for Juniper Biomedical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Juniper Biomedical
2 people are tracked at Juniper Biomedical (2 in leadership).
| Name | Role | Group |
|---|---|---|
Mario Romero Ortega | Co-Founder & CSO | Leadership |
David N Constantine | Co-Founder & CEO | Leadership |
Complete people profiles for Juniper Biomedical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Juniper Biomedical
3 dated milestones of Juniper Biomedical across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Juniper Biomedical is founded.
- Funding First funding round of $2.0M.
- Funding Latest funding round, Grant, of $1.0M.
Competitors of Juniper Biomedical
Juniper Biomedical has 9 listed competitors in our database, 7 of them funded. They include Minze Health, INNOVO, Jude, Starling Medical and inContAlert, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| minzehealth.com | 2015 | Antwerp, Belgium | $9.46M | – | Diagnosis and monitoring solutions for voiding disorders are offered. | |
| myinnovo.com | 2016 | Pleasanton, United States | – | – | Women's urinary incontinence is managed by wearable pelvic floor trainers. | |
| wearejude.com | 2021 | London, United Kingdom | $6.41M | 3 | Jude is focused on bladder health and protection products. | |
| starlingmedical.com | 2020 | Houston, United States | $12.29M | – | AI-based platform is developed for urinary tract infection detection. | |
| incontalert.de | 2017 | Bayreuth, Germany | $1.61M | – | Wearable sensor and mobile app for bladder monitoring are provided. | |
| devicare.com | 2012 | Barcelona, Spain | $7.13M | – | Home solutions for chronic disease diagnosis and monitoring are developed. | |
| toilabs.com | 2015 | San Francisco, United States | – | – | Developer of lower digestive and urinary flow monitoring device | |
| medipee.com | 2017 | Moers, Germany | $249,353 | 10 | Portable device for real-time urine analysis is developed. | |
| crimsonhealthcare.in | 2015 | Delhi, India | $439,262 | – | Medical devices for ostomy management are developed and supplied. |
Detailed competitors of Juniper Biomedical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Juniper Biomedical
The website of Juniper Biomedical (juniperbiomedical.com) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 39.7% vs previous month
Top companies in Health Monitoring & Wearables
10 companies that operate in the same segment as Juniper Biomedical (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | USD 398.5 M | 1,632 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | USD 275.25 M | 701 | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Juniper Biomedical
Complete news archive for Juniper Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Juniper Biomedical
Juniper Biomedical was founded in 2019 and raised its 1st funding round 5 years after it was founded.
Juniper Biomedical is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
David N Constantine is the current CEO of Juniper Biomedical. They have also founded this company.
Juniper Biomedical is a funded company, having raised a total of $2M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Apr 2024.
Juniper Biomedical was founded in 2019 in Worcester, United States, within the biomedical sector. A platform is operated to deliver therapy for pelvic health conditions through neuromodulation techniques. Normal neuromuscular function is restored in damaged pelvic floor tissue, while bladder activity is calmed. Treatment is focused on urinary incontinence, bowel incontinence, pelvic pain, sexual dysfunction, and related issues, with services accessible via the domain juniperbiomedical.com.
Juniper Biomedical's top competitors include Minze Health, INNOVO and Starling Medical.
Juniper Biomedical offers Neuromodulation Platform.
Juniper Biomedical has 5 investors. Key investors include NIH, Aatma Capital, Beacon Angels, Hub Angels, and Auroral Holdings.